Published in J Infect Dis on November 11, 2002
Persistent viral pathogens and cognitive impairment across the life course in the third national health and nutrition examination survey. J Infect Dis (2013) 2.14
Neuropathogenesis of congenital cytomegalovirus infection: disease mechanisms and prospects for intervention. Clin Microbiol Rev (2009) 1.90
Cytopathic effects of the cytomegalovirus-encoded apoptosis inhibitory protein vMIA. J Cell Biol (2006) 1.28
Apoptosis in animal models of virus-induced disease. Nat Rev Microbiol (2009) 1.19
Caspase inhibition protects against reovirus-induced myocardial injury in vitro and in vivo. J Virol (2004) 1.18
Towards an understanding of the herpes simplex virus type 1 latency-reactivation cycle. Interdiscip Perspect Infect Dis (2010) 1.05
Infectious agents and neurodegeneration. Mol Neurobiol (2012) 1.03
Novel strategy for treatment of viral central nervous system infection by using a cell-permeating inhibitor of c-Jun N-terminal kinase. J Virol (2007) 1.01
Global research priorities for infections that affect the nervous system. Nature (2015) 1.01
Exposure to the viral by-product dsRNA or Coxsackievirus B5 triggers pancreatic beta cell apoptosis via a Bim / Mcl-1 imbalance. PLoS Pathog (2011) 0.96
A brain slice culture model of viral encephalitis reveals an innate CNS cytokine response profile and the therapeutic potential of caspase inhibition. Exp Neurol (2011) 0.92
Caspase-3 activation is required for reovirus-induced encephalitis in vivo. J Neurovirol (2010) 0.89
The ribonucleotide reductase R1 subunits of herpes simplex virus 1 and 2 protect cells against poly(I · C)-induced apoptosis. J Virol (2011) 0.86
Viral mitochondria-localized inhibitor of apoptosis (UL37 exon 1 protein) does not protect human neural precursor cells from human cytomegalovirus-induced cell death. J Gen Virol (2012) 0.77
Differences in T cell cytotoxicity and cell death mechanisms between progressive multifocal leukoencephalopathy, herpes simplex virus encephalitis and cytomegalovirus encephalitis. Acta Neuropathol (2016) 0.75
Herpes simplex encephalitis is linked with selective mitochondrial damage; a post-mortem and in vitro study. Acta Neuropathol (2016) 0.75
Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis. N Engl J Med (2005) 7.54
Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med (2000) 6.43
Varicella zoster virus, a cause of waxing and waning vasculitis: the New England Journal of Medicine case 5-1995 revisited. Neurology (1996) 4.02
Does Toll-like receptor 3 play a biological role in virus infections? Virology (2004) 2.73
Naturally acquired West Nile virus encephalomyelitis in transplant recipients: clinical, laboratory, diagnostic, and neuropathological features. Arch Neurol (2004) 2.71
Concussion in sports. Guidelines for the prevention of catastrophic outcome. JAMA (1991) 2.53
Electron transport chain defects in Alzheimer's disease brain. Neurology (1994) 2.51
West Nile virus neuroinvasive disease. Ann Neurol (2006) 2.42
Primary intraosseous meningioma. Case report. J Neurosurg (1995) 2.28
Toxic leukoencephalopathy. N Engl J Med (2001) 2.27
Human herpesvirus 8 DNA in CNS lymphomas from patients with and without AIDS. Neurology (1998) 2.17
Decrease in the numbers of dendritic cells and CD4+ T cells in cerebral perivascular spaces due to natalizumab. Arch Neurol (2008) 1.88
Rituximab-associated progressive multifocal leukoencephalopathy in rheumatoid arthritis. Arch Neurol (2011) 1.83
Giant cell glioblastoma and pleomorphic xanthoastrocytoma show different immunohistochemical profiles for neuronal antigens and p53 but share reactivity for class III beta-tubulin. Arch Pathol Lab Med (2003) 1.75
Rapid correction of hyponatremia causes demyelination: relation to central pontine myelinolysis. Science (1981) 1.52
Proximal nerve root spinal hemangioblastomas: presentation of three cases, MR appearance, and literature review. Surg Neurol (2004) 1.49
Herpesvirus infections of the nervous system. Nat Clin Pract Neurol (2007) 1.48
A rat glioma model, CNS-1, with invasive characteristics similar to those of human gliomas: a comparison to 9L gliosarcoma. J Neurooncol (1994) 1.47
CSF findings in 250 patients with serologically confirmed West Nile virus meningitis and encephalitis. Neurology (2005) 1.45
Molecular methods for diagnosis of viral encephalitis. Clin Microbiol Rev (2004) 1.42
Quantitative CSF PCR in Epstein-Barr virus infections of the central nervous system. Ann Neurol (2002) 1.38
The vasculopathy of varicella-zoster virus encephalitis. Ann Neurol (1995) 1.36
Diffuse Lewy body disease and progressive dementia. Neurology (1988) 1.31
Lymphomatosis cerebri as a cause of white matter dementia. Hum Pathol (2005) 1.30
An adult case of leukoencephalopathy with intracranial calcifications and cysts. Neurology (2006) 1.28
MEKK1 regulates calpain-dependent proteolysis of focal adhesion proteins for rear-end detachment of migrating fibroblasts. EMBO J (2003) 1.27
Glutathione binding to the Bcl-2 homology-3 domain groove: a molecular basis for Bcl-2 antioxidant function at mitochondria. J Biol Chem (2007) 1.26
Dual infections of the central nervous system with Epstein-Barr virus. J Infect Dis (2004) 1.24
Toluene abuse causes diffuse central nervous system white matter changes. Ann Neurol (1988) 1.24
Reovirus-induced neuronal apoptosis is mediated by caspase 3 and is associated with the activation of death receptors. J Neurovirol (2002) 1.23
Neutrophil degranulation and immunosuppression in patients with GBM: restoration of cellular immune function by targeting arginase I. Clin Cancer Res (2011) 1.22
Bell's palsy--is glucocorticoid treatment enough? N Engl J Med (2007) 1.22
West Nile virus meningoencephalitis. Nat Clin Pract Neurol (2006) 1.22
Central pontine myelinolysis at autopsy; a twelve year retrospective analysis. J Neurol Sci (1996) 1.22
An algorithmic approach to the brain biopsy--part II. Arch Pathol Lab Med (2006) 1.21
Preherpetic neuralgia. Neurology (1991) 1.20
Progressive multifocal leukoencephalopathy, efalizumab, and immunosuppression: a cautionary tale for dermatologists. Arch Dermatol (2009) 1.19
Interobserver reproducibility among neuropathologists and surgical pathologists in fibrillary astrocytoma grading. J Neurol Sci (2000) 1.19
Apoptosis in animal models of virus-induced disease. Nat Rev Microbiol (2009) 1.19
N-Methyl-D-aspartate receptor subunit proteins and their phosphorylation status are altered selectively in Alzheimer's disease. J Neurol Sci (2001) 1.18
Caspase inhibition protects against reovirus-induced myocardial injury in vitro and in vivo. J Virol (2004) 1.18
Reovirus-induced apoptosis requires mitochondrial release of Smac/DIABLO and involves reduction of cellular inhibitor of apoptosis protein levels. J Virol (2002) 1.18
Use of PCR for the diagnosis of herpesvirus infections of the central nervous system. J Clin Virol (2002) 1.17
The value of cerebrospinal fluid antiviral antibody in the diagnosis of neurologic disease produced by varicella zoster virus. J Neurol Sci (1998) 1.17
Two distinct phases of virus-induced nuclear factor kappa B regulation enhance tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in virus-infected cells. J Biol Chem (2003) 1.14
Brain metastases from hepatocellular carcinoma in US patients. J Neurooncol (2006) 1.14
Wallenberg syndrome caused by CSF metastasis from malignant intraventricular meningioma. Clin Neuropathol (1986) 1.14
Identification of growth arrest and DNA-damage-inducible gene beta (GADD45beta) as a novel tumor suppressor in pituitary gonadotrope tumors. Endocrinology (2011) 1.14
JNK regulates the release of proapoptotic mitochondrial factors in reovirus-infected cells. J Virol (2004) 1.13
Minocycline delays disease onset and mortality in reovirus encephalitis. Exp Neurol (2005) 1.11
Recurrent dermatomal vesicular skin lesions: a clue to diagnosis of herpes simplex virus 2 meningitis. Arch Neurol (2003) 1.09
The effects of toluene on the central nervous system. J Neuropathol Exp Neurol (2004) 1.09
Growth hormone tumor histological subtypes predict response to surgical and medical therapy. Endocrine (2014) 1.09
Neurobehavioral presentations of brain neoplasms. West J Med (1995) 1.09
Fulminant ascending paralysis as a delayed sequela of diethylene glycol (Sterno) ingestion. Neurology (2002) 1.08
Regional differences in viral growth and central nervous system injury correlate with apoptosis. J Virol (2004) 1.08
Hematological neoplasms with first presentation as spinal cord compression syndromes: a 10-year retrospective series and review of the literature. Clin Neuropathol (2003) 1.07
Selective regional loss of exocytotic presynaptic vesicle proteins in Alzheimer's disease brains. J Neurol Sci (2000) 1.05
In vitro and in vivo evaluation of PEDOT microelectrodes for neural stimulation and recording. IEEE Trans Neural Syst Rehabil Eng (2011) 1.05
The uninvited guest: JC virus infection of neurons in PML. Neurology (2003) 1.05
Simian varicella virus infects ganglia before rash in experimentally infected monkeys. Virology (2001) 1.04
PARP1 expression in pediatric central nervous system tumors. Pediatr Blood Cancer (2009) 1.04
Reovirus-induced alterations in gene expression related to cell cycle regulation. J Virol (2002) 1.03
Characterization of a continuous human glioma cell line DBTRG-05MG: growth kinetics, karyotype, receptor expression, and tumor suppressor gene analyses. In Vitro Cell Dev Biol (1992) 1.03
Progressive multifocal leukoencephalopathy: can we reduce risk in patients receiving biological immunomodulatory therapies? Ann Neurol (2010) 1.03
Genetic characterization of gliomas arising in patients with multiple sclerosis. J Neurooncol (2012) 1.02
Phase I trial of hypofractionated intensity-modulated radiotherapy with temozolomide chemotherapy for patients with newly diagnosed glioblastoma multiforme. Int J Radiat Oncol Biol Phys (2010) 1.02
Unique molecular characteristics of radiation-induced glioblastoma. J Neuropathol Exp Neurol (2007) 1.02
Novel strategy for treatment of viral central nervous system infection by using a cell-permeating inhibitor of c-Jun N-terminal kinase. J Virol (2007) 1.01
The immunoglobulin G heavy chain repertoire in multiple sclerosis plaques is distinct from the heavy chain repertoire in peripheral blood lymphocytes. Clin Immunol (2001) 1.01
Impact of rituximab-associated B-cell defects on West Nile virus meningoencephalitis in solid organ transplant recipients. Clin Transplant (2009) 1.01
Progressive multifocal leukoencephalopathy and apoptosis of infected oligodendrocytes in the central nervous system of patients with and without AIDS. Arch Neurol (2002) 1.01
Reovirus-induced alteration in expression of apoptosis and DNA repair genes with potential roles in viral pathogenesis. J Virol (2003) 1.00
Sudden deterioration and death in patients with benign tumors of the third ventricle area. J Neurosurg (1986) 1.00
Infectious simian varicella virus expressing the green fluorescent protein. J Neurovirol (1998) 0.99
Osteochondroma of the convexity: pathologic-neuroimaging correlates of a lesion that mimics high-grade meningioma. J Neurooncol (2009) 0.98
Fas-mediated apoptotic signaling in the mouse brain following reovirus infection. J Virol (2009) 0.97
West Nile virus growth is independent of autophagy activation. Virology (2012) 0.97
Neuropathologic observations in electrolyte-induced myelinolysis in the rat. J Neuropathol Exp Neurol (1982) 0.96
JAK-STAT signaling pathways are activated in the brain following reovirus infection. J Neurovirol (2007) 0.95
Novel nuclear herniations induced by nuclear localization of a viral protein. J Virol (2004) 0.95
Nonstructural protein sigma1s is a determinant of reovirus virulence and influences the kinetics and severity of apoptosis induction in the heart and central nervous system. J Virol (2005) 0.95
Neuro-intensive care of patients with acute CNS infections. Neurotherapeutics (2012) 0.94
Reovirus infection of the CNS enhances iNOS expression in areas of virus-induced injury. Exp Neurol (2005) 0.94
Progressive multifocal leukoencephalopathy and relapsing-remitting multiple sclerosis: a comparative study. Arch Neurol (2009) 0.93
Acute hemorrhagic leukoencephalitis: a critical entity for forensic pathologists to recognize. Am J Forensic Med Pathol (2010) 0.93
Daxx upregulation within the cytoplasm of reovirus-infected cells is mediated by interferon and contributes to apoptosis. J Virol (2013) 0.93
Progressive encephalitis three months after resolution of cutaneous zoster in a patient with AIDS. Ann Neurol (1986) 0.92
Colorado surveillance program for chronic wasting disease transmission to humans: lessons from 2 highly suspicious but negative cases. Arch Neurol (2007) 0.92
A brain slice culture model of viral encephalitis reveals an innate CNS cytokine response profile and the therapeutic potential of caspase inhibition. Exp Neurol (2011) 0.92
Inhibition of Rac GTPase triggers a c-Jun- and Bim-dependent mitochondrial apoptotic cascade in cerebellar granule neurons. J Neurochem (2005) 0.91
Death receptor-mediated apoptotic signaling is activated in the brain following infection with West Nile virus in the absence of a peripheral immune response. J Virol (2013) 0.91
Disrupted glutamate transporter expression in the spinal cord with acute flaccid paralysis caused by West Nile virus infection. J Neuropathol Exp Neurol (2009) 0.90
The proapoptotic Bcl-2 protein Bax plays an important role in the pathogenesis of reovirus encephalitis. J Virol (2011) 0.90
Toward a self-deploying shape memory polymer neuronal electrode. J Neural Eng (2006) 0.90
Initial management of acute bacterial meningitis in adults: summary of IDSA guidelines. Rev Neurol Dis (2006) 0.90